Dutch KSA Orders Endorphina to End Ties with Illegal Sites

The Dutch Gaming Authority (KSA) has issued a binding instruction to Endorphina Limited in Malta and Endorphina Ltd in Cyprus. Under the instruction, the provider must end its partnerships with sites that are accessible from the Netherlands and do not hold a KSA licence.

The regulator found that Endorphina's online casino games were available on unlicensed sites, that these sites still targeted Dutch players, and that they did not restrict player access. Investigators accessed Endorphina games on these sites in a total of 15 instances between 12 January and 19 February 2026. Games such as Fortune Snake, Bad Santa, Hell Hot 100 and Royal X-Mass were among these examples. The KSA stated that this approach gave access to at least 28 unlicensed sites and noted that the sites had made no attempt to block access.

The compliance period for the instruction is two weeks, beginning on Monday, 2 November. The KSA explained that no sanctions or penalties have currently been imposed on Endorphina and that the aim is to secure compliance through the instruction. The regulator argued that licensed providers, operators and their intermediaries are prohibited from partnering with sites in the Netherlands that do not hold a licence and are open to local players.

Endorphina said it has received the instruction but that the regulator's assumption may not be entirely accurate. The company stated that it uses its Malta and Cyprus units to serve different markets, that there is no evidence that games were deliberately supplied to unlicensed providers in the Netherlands, and that it has received no information from the investigation into third-party content misuse. The KSA responded that this objection is not relevant to the instruction.

The report notes that the Netherlands is looking for new tools to pressure companies that can influence illegal sites. It also says that Sweden introduced rules a few years ago that hold providers responsible, but that local interpretations of these measures have created uncertainty and put businesses in a difficult position, as Endorphina has pointed out.